UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Do older people know why they take benzodiazepines? A national French cross‐sectional survey of long‐term consumers

International journal of geriatric psychiatry, 2020-08, Vol.35 (8), p.870-876

2020

Volltextzugriff (PDF)

Change in the regulatory framework for zolpidem: What is the impact on the landscape of the prescription of sedative medications? The French national ZORRO study

British journal of clinical pharmacology, 2021-08, Vol.87 (8), p.3310-3319

2021

Volltextzugriff (PDF)

ZORRO: When the mask falls off—Comment

British journal of clinical pharmacology, 2022-05, Vol.88 (5), p.2450-2451

2022

Volltextzugriff (PDF)

Relevance of CYP2B6 and CYP2D6 genotypes to methadone pharmacokinetics and response in the OPAL study

British journal of clinical pharmacology, 2019-07, Vol.85 (7), p.1538-1543

2019

Volltextzugriff (PDF)

Regulatory Framework Implementation for the Prescription of Zolpidem in France, What Impact in the Older People?

International journal of environmental research and public health, 2021-11, Vol.18 (22), p.12099

2021

Volltextzugriff (PDF)

Drug-induced depressive symptoms: An update through the WHO pharmacovigilance database

Journal of affective disorders, 2024-04, Vol.350, p.452-467

2024

Volltextzugriff (PDF)

Benzodiazepine withdrawal in older people: what is the prevalence, what are the signs, and which patients?

European journal of clinical pharmacology, 2021-02, Vol.77 (2), p.171-177

2021

Volltextzugriff (PDF)

Are Seniors Dependent on Benzodiazepines? A National Clinical Survey of Substance Use Disorder

Clinical pharmacology and therapeutics, 2021-02, Vol.109 (2), p.528-535

2021

Volltextzugriff (PDF)

Evolution of the profiles of new psychotropic drug users before and during the COVID-19 crisis: an original longitudinal approach through multichannel sequence analysis using the French health-care database

European archives of psychiatry and clinical neuroscience, 2024-03

2024

Volltextzugriff (PDF)

New Psychoactive Substances, New Behaviours, New Drug-drug Interactions: Pharmacology of a Slam Session

Current drug metabolism, 2023-01, Vol.24 (2), p.80-91

2023

Volltextzugriff (PDF)

Dynamics of postural control during repetitive transcranial magnetic stimulation in an adult with major depressive disorder

Australian and New Zealand journal of psychiatry, 2018-03, Vol.52 (3), p.291-293

2018

Volltextzugriff (PDF)

French national addictovigilance follow-up of zolpidem between 2014 and 2020: evolution of drug abuse, misuse and dependence before and after the regulatory change

European journal of public health, 2023-04, Vol.33 (2), p.169-175

2023

Volltextzugriff (PDF)

Cannabinoid Hyperemesis Syndrome Among Pregnant Women: Beyond Diagnosis--Potentially Harmful Consequences

Journal of studies on alcohol and drugs, 2020-11, Vol.81 (6), p.824-825

2020

Volltextzugriff (PDF)

Nitrous oxide in France: Evolution of complications reported to the French monitoring system in the context of information from health authorities and regulatory measures

The International journal of drug policy, 2023-10, p.104172, Article 104172

2023

Volltextzugriff (PDF)

Naltrexone Use in Treating Hypersexuality Induced by Dopamine Replacement Therapy: Impact of OPRM1 A/G Polymorphism on Its Effectiveness

International journal of molecular sciences, 2020-04, Vol.21 (8), p.3002

2020

Volltextzugriff (PDF)

Did the pattern of use of zolpidem change since the enforcement of a new prescription rule? A latent class analysis using the French health insurance database

Expert opinion on drug safety, 2022-09, Vol.21 (9), p.1225-1234

2022

Volltextzugriff (PDF)

"Naloxone? Not for me!" First cross-assessment by patients and healthcare professionals of the risk of opioid overdose

Harm reduction journal, 2024-01, Vol.21 (1), p.20-10, Article 20

2024

Volltextzugriff (PDF)

Characterization of antipsychotic utilization before clozapine initiation for individuals with schizophrenia: an innovative visualization of trajectories using French National Health Insurance data

Epidemiology and psychiatric sciences, 2023-09, Vol.32, p.e59-e59, Article e59

2023

Volltextzugriff (PDF)

Prevalence of Coaddictions and Rate of Successful Treatment Among a French Sample of Opioid-Dependent Patients With Long-Term Opioid Substitution Therapy: The OPAL Study

Frontiers in psychiatry, 2019-10, Vol.10, p.726-726

2019

Volltextzugriff (PDF)

CYP1A2 and tobacco interaction: a major pharmacokinetic challenge during smoking cessation

Drug metabolism reviews, 2021-01, Vol.53 (1), p.30-44

2021

Volltextzugriff (PDF)

A revisited version of the disputatio for pharmacological training: An educational study

Therapie, 2024-07, Vol.79 (4), p.435-441

2024

Volltextzugriff (PDF)

What about regular hematological monitoring during clozapine treatment? A compliance analysis using the French health insurance database

Expert opinion on drug safety, 2021-10, Vol.20 (10), p.1247-1256

2021

Volltextzugriff (PDF)

Perception of the Regulatory Change for Zolpidem Prescription by French General Practitioners and Its Relation to Prescription Behavior

Journal of clinical medicine, 2022-04, Vol.11 (8), p.2176

2022

Volltextzugriff (PDF)

Nitrous oxide: a unique official French addictovigilance national survey

Frontiers in public health, 2023-05, Vol.11, p.1167746-1167746

2023

Volltextzugriff (PDF)

Cathinone Use Disorder in the Context of Slam Practice: New Pharmacological and Clinical Challenges

Frontiers in psychiatry, 2020-07, Vol.11, p.705-705

2020

Volltextzugriff (PDF)

1 – 25 von 54

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(46)

Publikationsform

Artikel
(53)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(36)
Science & Technology
(36)
Life Sciences
(23)
Humans
(17)
Patients
(11)
Pharmacology & Pharmacy
(11)
Psychiatry
(11)
Female
(8)
Zolpidem
(8)
Benzodiazepines
(7)
Male
(6)
Narcotics
(6)
Pharmacology
(6)
Public Health
(6)
Adult
(5)
Drug Abuse
(5)
Methadone
(5)
Psychotropic Drugs
(5)
Public, Environmental & Occupational Health
(5)
Substance Abuse
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Do older people know why they take benzodiazepines? A national French cross‐sectional survey of long‐term consumers

Change in the regulatory framework for zolpidem: What is the impact on the landscape of the prescription of sedative medications? The French national ZORRO study

ZORRO: When the mask falls off—Comment

Relevance of CYP2B6 and CYP2D6 genotypes to methadone pharmacokinetics and response in the OPAL study

Regulatory Framework Implementation for the Prescription of Zolpidem in France, What Impact in the Older People?

Drug-induced depressive symptoms: An update through the WHO pharmacovigilance database

Benzodiazepine withdrawal in older people: what is the prevalence, what are the signs, and which patients?

Are Seniors Dependent on Benzodiazepines? A National Clinical Survey of Substance Use Disorder

Evolution of the profiles of new psychotropic drug users before and during the COVID-19 crisis: an original longitudinal approach through multichannel sequence analysis using the French health-care database

New Psychoactive Substances, New Behaviours, New Drug-drug Interactions: Pharmacology of a Slam Session

Dynamics of postural control during repetitive transcranial magnetic stimulation in an adult with major depressive disorder

French national addictovigilance follow-up of zolpidem between 2014 and 2020: evolution of drug abuse, misuse and dependence before and after the regulatory change

Cannabinoid Hyperemesis Syndrome Among Pregnant Women: Beyond Diagnosis--Potentially Harmful Consequences

Nitrous oxide in France: Evolution of complications reported to the French monitoring system in the context of information from health authorities and regulatory measures

Naltrexone Use in Treating Hypersexuality Induced by Dopamine Replacement Therapy: Impact of OPRM1 A/G Polymorphism on Its Effectiveness

Did the pattern of use of zolpidem change since the enforcement of a new prescription rule? A latent class analysis using the French health insurance database

"Naloxone? Not for me!" First cross-assessment by patients and healthcare professionals of the risk of opioid overdose

Characterization of antipsychotic utilization before clozapine initiation for individuals with schizophrenia: an innovative visualization of trajectories using French National Health Insurance data

Prevalence of Coaddictions and Rate of Successful Treatment Among a French Sample of Opioid-Dependent Patients With Long-Term Opioid Substitution Therapy: The OPAL Study

CYP1A2 and tobacco interaction: a major pharmacokinetic challenge during smoking cessation

A revisited version of the disputatio for pharmacological training: An educational study

What about regular hematological monitoring during clozapine treatment? A compliance analysis using the French health insurance database

Perception of the Regulatory Change for Zolpidem Prescription by French General Practitioners and Its Relation to Prescription Behavior

Nitrous oxide: a unique official French addictovigilance national survey

Cathinone Use Disorder in the Context of Slam Practice: New Pharmacological and Clinical Challenges

Suchergebnisse filtern